Colgate Palmolive CO Form 4 insider transactions

A Colgate-Palmolive executive, Prabha Parameswaran, sold 229 shares of common stock to cover tax liabilities related to previously granted restricted stock units.

Gregory Malcolm, EVP and Controller at Colgate-Palmolive, sold 42 shares of common stock to cover tax liabilities related to restricted stock units.

Jennifer Daniels, CLO and Secretary at Colgate-Palmolive, reported a transaction involving the withholding of 168 common stock shares for tax liabilities.

A Form 4 filing reveals that Colgate-Palmolive's EVP and Controller, Gregory Malcolm, sold 1,054 shares and gifted 1,387 shares of company stock.

Colgate-Palmolive's CEO, Noel Wallace, sold 33,333 shares of common stock at $95 per share on November 22, 2024, as part of a pre-arranged trading plan.

Chief Financial Officer of Colgate-Palmolive, Stanley Sutula III, executed stock options and sold shares to cover the exercise price and related taxes.

Panagiotis Tsourapas, a Group President at Colgate-Palmolive, sold 20,032 shares of common stock at an average price of $93.3012 on November 4, 2024.

Stanley Sutula III, CFO of Colgate-Palmolive, exercised stock options and sold 50,000 shares of common stock on November 1, 2024.

Director Brian Newman reports acquiring and disposing of Colgate-Palmolive common stock on October 1, 2024.

Director Lisa Edwards acquired 89 shares of Colgate-Palmolive common stock through a deferred compensation plan on October 1, 2024.

Director John P. Bilbrey acquired 201 shares of Colgate-Palmolive common stock at $105.24 per share on October 1, 2024, according to a recent SEC filing.

Director Lorrie M. Norrington increased her holdings in Colgate-Palmolive through a deferred compensation plan, acquiring 249 shares at $105.24 each.

Colgate-Palmolive CEO Noel Wallace reports acquisition of restricted stock units and stock options, as well as the disposal of shares to cover tax liabilities.

Panagiotis Tsourapas, a Group President at Colgate-Palmolive, reported the acquisition of restricted stock units and stock options, as well as the disposal of shares to cover tax liabilities.

Chief Financial Officer of Colgate-Palmolive, Stanley Sutula III, reports acquisition of restricted stock units and stock options, as well as disposition of shares for tax liability.

Prabha Parameswaran, Group President of Growth & Strategy at Colgate-Palmolive, reports acquisition and disposal of company stock and stock options.

EVP and Controller Gregory Malcolm reports acquisition of restricted stock units and stock options, along with tax-related share withholding.

John W. Kooyman, Chief of Staff at Colgate-Palmolive, reports acquisition of restricted stock units and stock options, as well as disposition of shares for tax obligations.

Jennifer Daniels, CLO and Secretary of Colgate-Palmolive, reports acquisition of restricted stock units and stock options, as well as a disposition of shares to cover tax liabilities.

Chief Human Resources Officer Sally Massey reported the acquisition and disposal of Colgate-Palmolive stock and stock options.

Gregory Malcolm, EVP and Controller at Colgate-Palmolive, reports a transaction involving common stock due to tax liability from vesting restricted stock units.

Director Hundmejean Martina reports exercising stock options and selling shares of Colgate-Palmolive common stock on August 23, 2024.

Panagiotis Tsourapas, Group President, Europe & Developing Markets at Colgate-Palmolive, exercised stock options and sold shares on August 8, 2024.

Jennifer Daniels, CLO and Secretary of Colgate-Palmolive, exercised stock options and sold shares to cover the exercise price and related taxes.

Sally Massey, Chief Human Resources Officer at Colgate-Palmolive, exercised stock options and sold shares to cover the exercise price and related taxes.

John W. Kooyman, Chief of Staff at Colgate-Palmolive, exercised stock options and sold shares on August 6, 2024.

Gregory Malcolm, EVP and Controller of Colgate-Palmolive, exercised stock options and sold shares to cover the exercise price and related taxes.

Panagiotis Tsourapas, Group President, Eur& Developing Mkts at Colgate-Palmolive, exercised stock options and sold shares on July 31, 2024.

Director Lorrie M Norrington acquired 274 shares of Colgate-Palmolive common stock at $95.61 per share on July 1, 2024.

Director Brian Newman reports acquisition and disposal of Colgate-Palmolive stock, including shares acquired through a deferred compensation plan and shares held by a family trust.